Zoetis
ZTS
$165.18
Share price
-1.82%
Change (1 day)
-11.98%
Change (1 year)
Categories
P/S ratio for Zoetis (ZTS)
P/S ratio as of January 2023 (TTM): 9.61
According to Zoetis's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 9.61481. At the end of 2022 the company had a P/S ratio of 8.67.
P/S ratio history for Zoetis from 2013 to 2022
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2022 | 8.67 | -41.61% |
| 2021 | 14.8 | 26% |
| 2020 | 11.8 | 17.21% |
| 2019 | 10.1 | 42.76% |
| 2018 | 7.04 | 6.47% |
| 2017 | 6.61 | 22.31% |
| 2016 | 5.41 | 8.12% |
| 2015 | 5.00 | 10.96% |
| 2014 | 4.51 | 25.8% |
| 2013 | 3.58 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | 2.47 | -74.35% | 🇺🇸 USA |
 Eli Lilly LLY | 11.1 | 15.62% | 🇺🇸 USA |
 Sanofi SNY | 2.59 | -73.10% | 🇫🇷 France |
 Merck MRK | 4.53 | -52.88% | 🇺🇸 USA |
 Phibro Animal Health
PAHC | 0.6433 | -93.31% | 🇺🇸 USA |
 Kindred Biosciences
KIN | N/A | -100.00% | 🇺🇸 USA |
 Heska Corporation
HSKA | 3.65 | -62.02% | 🇺🇸 USA |